- Reexpression of Human Somatostatin Receptor Gene 2 Gene Mediated by Oncolytic Adenovirus Increases Antitumor Activity of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand against Pancreatic Cancer
[作者:Zhang, ZW; Huang, YB; Newman, K; Gu, JF; Zhang, XM; Wu, H; Zhao, M; Xianyu, ZQ; Liu, XY,期刊:Clinical Cancer Research, 页码:5154-5160 , 文章类型: Article,,卷期:2009年15-16]
- Purpose: Pancreatic cancer continues to pose an enormous challenge to clinicians and cancer scientists. Clinical studies show that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) exerts a potent and tumor...
- Epigenetic Deregulation of DNA Repair and Its Potential for Therapy
[作者:Hegi, ME; Sciuscio, D; Murat, A; Levivier, M; Stupp, R,期刊:Clinical Cancer Research, 页码:5026-5031 , 文章类型: Article,,卷期:2009年15-16]
- Epigenetic silencing of essential components of DNA repair pathways is a common event in many tumor types, and comprise O6-methylguanine-DNA methyltransferase (MGMT), human mut L homolog 1 (hMLH1), Werner syndrome gene (...
- Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2
[作者:Evans, DG; Kalamarides, M; Hunter-Schaedle, K; Blakeley, J; Allen, J; Babovic-Vuskanovic, D; Belzberg, A; Bollag, G; Chen, RH; DiTomaso, E; Golfinos, J; Harris, G; Jacob, A; Kalpana, G; Karajannis, M; Korf, B; Kurzrock, R; Law, M; McClatchey, A; Packer, R; Roehm, P; Rubenstein, A; Slattery, W; Tonsgard, JH; Welling, DB; Widemann, B; Yohay, K; Giovannini, M,期刊:Clinical Cancer Research, 页码:5032-5039 , 文章类型: Article,,卷期:2009年15-16]
- Purpose: Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder associated primarily with bilateral schwannomas seen on the superior vestibular branches of the eighth cranial nerves. Significant morbidity c...
- PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
[作者:Kalinsky, K; Jacks, LM; Heguy, A; Patil, S; Drobnjak, M; Bhanot, UK; Hedvat, CV; Traina, TA; Solit, D; Gerald, W; Moynahan, ME,期刊:Clinical Cancer Research, 页码:5049-5059 , 文章类型: Article,,卷期:2009年15-16]
- Purpose: In breast cancer, somatic mutations in the PIK3CA gene are common. The prognostic implication of these activating mutations remains uncertain as moderately sized studies have yielded variable outcomes. Our aim w...
- miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
[作者:Adam, L; Zhong, M; Choi, W; Qi, W; Nicoloso, M; Arora, A; Calin, G; Wang, H; Siefker-Radtke, A; McConkey, D; Bar-Eli, M; Dinney, C,期刊:Clinical Cancer Research, 页码:5060-5072 , 文章类型: Article,,卷期:2009年15-16]
- Purpose: The epithelial-to-mesenchymal transition (EMT) is a cell development-regulated process in which noncoding RNAs act as crucial modulators. Recent studies have implied that EMT may contribute to resistance to epid...
- MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
[作者:Gramantieri, L; Fornari, F; Ferracin, M; Veronese, A; Sabbioni, S; Calin, GA; Grazi, GL; Croce, CM; Bolondi, L; Negrini, M,期刊:Clinical Cancer Research, 页码:5073-5081 , 文章类型: Article,,卷期:2009年15-16]
- Deregulated cell proliferation and apoptosis play a major role in hepatocellular carcinoma (HCC). MicroRNAs participate in the modulation of key molecules linked to hepatocarcinogenesis. Purpose: This study aims to inves...
- Profiling of Chemonaive Osteosarcoma and Paired-Normal Cells Identifies EBF2 as a Mediator of Osteoprotegerin Inhibition to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis
[作者:Patino-Garcia, A; Zalacain, M; Folio, C; Zandueta, C; Sierrasesumaga, L; Julian, MS; Toledo, G; De Las Rivas, J; Lecanda, F,期刊:Clinical Cancer Research, 页码:5082-5091 , 文章类型: Article,,卷期:2009年15-16]
- Purpose: Osteosarcoma is the most prevalent bone tumor in children and adolescents. At present, the mechanisms of initiation, maintenance, and metastasis are poorly understood. The purpose of this study was to identify r...
- CIP2A Is Associated with Human Breast Cancer Aggressivity
[作者:Come, C; Laine, A; Chanrion, M; Edgren, H; Mattila, E; Liu, XL; Jonkers, J; Ivaska, J; Isola, J; Darbon, JM; Kallioniemi, O; Thezenas, S; Westermarck, J,期刊:Clinical Cancer Research, 页码:5092-5100 , 文章类型: Article,,卷期:2009年15-16]
- Purpose: To investigate the clinical relevance of the recently characterized human oncoprotein cancerous inhibitor of protein phosphatase 2A (CIP2A) in human breast cancer. Experimental Design: CIP2A expression (mRNA and...
- Elevated Cutaneous Smad Activation Associates with Enhanced Skin Tumor Susceptibility in Organ Transplant Recipients
[作者:Harradine, KA; Ridd, K; Saunier, EF; Clermont, FF; Perez-Losada, J; Moore, DH; Epstein, EH; Bastian, BC; Akhurst, RJ,期刊:Clinical Cancer Research, 页码:5101-5107 , 文章类型: Article,,卷期:2009年15-16]
- Purpose: Nonmelanoma skin cancer incidence is enhanced >50-fold in patients taking antirejection drugs (ARD) following organ transplantation. Preclinical studies suggest that ARD treatment increases transforming growth f...
- Heat Shock Protein 90 Inhibitor BIIB021 (CNF2024) Depletes NF-kB and Sensitizes Hodgkin's Lymphoma Cells for Natural Killer Cell-Mediated Cytotoxicity
[作者:Boll, B; Eltaib, F; Reiners, KS; von Tresckow, B; Tawadros, S; Simhadri, VR; Burrows, FJ; Lundgren, K; Hansen, HP; Engert, A; von Strandmann, EP,期刊:Clinical Cancer Research, 页码:5108-5116 , 文章类型: Article,,卷期:2009年15-16]
- Purpose: In Hodgkin's lymphoma, constitutive activation of NF-kB promotes tumor cell survival and proliferation. The molecular chaperone heat shock protein 90 (HSP90) has immune regulatory activity and supports the activ...
- Inhibition of Insulin-Like Growth Factor 1 Receptor by CP-751,871 Radiosensitizes Non-Small Cell Lung Cancer Cells
[作者:Iwasa, T; Okamoto, I; Suzuki, M; Hatashita, E; Yamada, Y; Fukuoka, M; Ono, K; Nakagawa, K,期刊:Clinical Cancer Research, 页码:5117-5125 , 文章类型: Article,,卷期:2009年15-16]
- Purpose: Therapeutic strategies that target the insulin-like growth factor I receptor (IGF-1R) hold promise for a wide variety of cancers. We have now investigated the effect of CP-751,871, a fully human monoclonal antib...
|